MedTrace Logo

The Effect of Omega-3 FA on Glucose and Lipid Homeostasis Disorders in Obese/Diabetic Patients

NCT03708887 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 415

Last updated 2024-07-12

No results posted yet for this study

Summary

A double-blind and placebo-controlled study is conducted in the current human study.

The purpose of this study is to investigate the effects of n-3 PUFA intervention on glucose and lipid homeostasis in Chinese diabetic/obese patients.

Conditions

  • Hyperglycaemia (Diabetic)
  • Hyperlipidemias

Interventions

DRUG

Low dose omega-3 fatty acid supplementation

Omega-3 fatty acids capsules, 1.5 g/d by mouth for 1 year

DRUG

High dose omega-3 fatty acid supplementation

Omega-3 fatty acids capsules, 3 g/d by mouth for 1 year

DRUG

Control drug

Matching placebo capsules,3 g/d by mouth for 1 year

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-10
Primary Completion
2022-01-02
Completion
2022-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03708887 on ClinicalTrials.gov